Culturing Melanoma and Melanocyte Cells
Corresponding Organization : University of Arizona
Variable analysis
- Increasing concentrations of vemurafenib (0.1–5 µM)
- Generation of A375 cells resistant to the BRAF^V600E-kinase inhibitor vemurafenib (A375R)
- Malignant human melanoma cell lines (A375, LOX-IMVI, G-361)
- RPMI medium (10% FBS and 2 mM L-glutamine) or McCoy's 5a medium (10% FBS)
- Primary human epidermal melanocytes (HEMa) cultured in Medium 154 medium supplemented with HMGS-2 growth supplement
- Human diploid dermal fibroblasts (Hs27) cultured as described previously
- Cells maintained at 37 °C in 5% CO2, 95% air in a humidified incubator
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!